Abstract
The hormone treatment of prostatic cancer is based on the dependence of prostatic cells on the stimulus of androgens for their development and maintenance. The prostate gland remains small in eunuchoid individuals throughout puberty and shrinks after castration or the suppression of androgens, direct or indirect, by administration of estrogens (Huggins and Clarke, 1940). The extension of this study to the treatment of prostatic cancer as described by Huggins and Hodges (1941) showed that castration or estrogen therapy produced a dramatic response in about 80% of patients with disseminated prostatic cancer. If prostatic cancer is not amenable to cure by radical prostatectomy (stage A or B in Whitmore’s classification, 1963), hormone therapy should be instituted. Barnes (1959) has shown that delay in instituting anti-androgen therapy after prostatic cancer has been diagnosed results in a shorter average survival than if it had been begun immediately.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Barnes, R. W., and W. C. Emergy: Management of early prostatic cancer. Calif. Medicine (Baltimore) 91, 57 (1959).
Behnam, A.M., C.V. Hodges, and J. Thye: Microradioautography in internal irradiation of the prostate. J. Urol. (Baltimore) 88, 805 (1962).
Behnam, A.M., and J. M. Ocker, jr.: Perfusion of the isolated prostatic circulation with radioactive phosphorus (P32). J. Urol. (Baltimore) 84, 753 (1960).
Birke, G., C. Franksson, and L. O. Plantin: Estrogen therapy in carcinoma of the prostate. Acta chir. scand. 109, 1 (1955).
Brendler, H.: Steroids in reactivated prostatic cancer. In Methods in hormone research, Vol. 4. New York: Academic Press 1965, pages 105–122.
Brendler, W. E. Chase, and W. W. Scott: Prostatic cancer. Further investigations of hormonal relationship. Arch. Surg. 61, 433 (1950).
Brendler, H., and B. S. Winkler: Effect of norethandrolone on 17-ketosteroid excretion in prostatic cancer patients. J. clin. Endocrin. 19, 183 (1953).
Christensen, B. G.: Hypofysectomi og Oestrinbehandlung, Copenhagen: Munksgaard 1944.
Colston, J. A. C., and H. Brendler: Endocrine therapy in carcinoma of the prostate: preparation of patients for radical perineal prostatectomy. Trans. Amer. Ass. gen.-urin. Surg. 38, 241 (1946).
Dao, T. L.-Y.: Present status of adrenalectomy in the palliation of the metastatic carcinoma of the prostate. In Proceedings of the 3rd National Cancer Conference. Philadelphia: Lippencott 1957, page 282.
Druckrey, H., and S. Raabe: Organ spezifische Chemotherapie des Krebses (Prostata-carcinom). Klin. Wschr. 30, 882 (1952).
Fergusson, J. D.: Tracer experiments showing the distribution and fate of injected phosphorylated oestrogens in cancer of the prostate. Brit. J. Urol. 33, 442 (1961).
Forrest, A. P., D.W. Blair, and J.N. Valentine: Screw-implantation of the pituitary with yttrium-90. Lancet 2, 192 (1958).
Franks, L. M.: The effects of age on the structure and response to oestrogens and testosterone of the mouse prostate in organ cultures. Brit. J. Cancer 13, 59 (1959).
Gallagher, T. F., W. F. Whitmore, jr., B. Zumoff, and F. Hellman: Studies in prostatic cancer before and after orchidectomy. Nat. Cancer Inst. Monogr. 12, 131 (1963).
Goodwin, D. A., D. S. Rasmussen-Taxdal, A. A. Ferreira, and W. W. Scott: Estrogen inhibition of androgen maintained prostatic secretion in the hypophysectomized dog. J. Urol. (Baltimore) 86, 134 (1961).
Grayhack, J. T., P. L. Bunce, S. W. Kearns, and W. W. Scott: Influence of the pituitary on prostatic response to androgen in the rat. Bull. Johns Hopk. Hosp. 96, 154 (1955).
Hodges, C.V., R.J. Moore, A.M. Behnam, and T. H. Lehman: Regional perfusion of inoperable prostatic cancer with radioactive phosphorus. J. Urol. (Baltimore) 92, 540 (1964).
Huggins,C., and D.M. Bergenstal: Surgery of the adrenals. J. Amer. med. Ass. 147, 101 (1951).
Huggins, C., and P. J. Clarke: Quantitative studies of prostatic secretion. II. The effect of castration and estrogen injection on normal and hyperplastic prostate glands of dogs. J. exp. Med. 72, 747 (1940).
Huggins, C., and C. V. Hodges: I. The effect of castration and of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer. Res. 1, 293 (1941).
Huggins, C., and W. W. Scott: Bilateral adrenalectomy in prostatic cancer: clinical features and urinary excretion of 17-ketosteroids and estrogens. Ann. Surg. 122, 1031 (1945).
JÖhnson, G., E. Diczfalusy, L. O. Plantin, L. Röhl, and G. Birke: Estradurin ® (polyestradiol phosphate) in the treatment of prostatic carcinoma. A. Clinical and steroid metabolic study. Acta endocr. (Kbh.) Suppl. 83, 3 (1963).
Kirchheim, D., and W. W. Scott: The effects of castration and sex hormones upon aminopeptidases and phosphatases of the rat prostate. Invest. Urol. 2, 393 (1965).
Knobil, E.: The relation of some steroid hormones to beta-glucuronidase activity. Endocrinology 50, 16 (1952).
Lasnitzki, I.: The effect of estrone alone and combined with 20-methylcholanthrene on mouse prostate glands grown in vitro. Cancer Res. 14, 632 (1954).
MacDonald, D. F., and M. J. Lotta: Aerobic glycolysis of human prostatic adenoma: in vitro inhibition by estrogen and by androgen and estrogen. Endocrinology 59, 153 (1956).
Maxfield, J. R., jr., G. S. Maxfield, and W. S. Maxfield: The use of radioactive phosphorus and testosterone in metastatic bone lesions from breast and prostate. Sth. med. J. (Bgham, Ala.) 51, 320 (1958).
Munger, H. V.: Are some prostatic carcinomas estrogen dependent? Trans. S. cent. Sect. Amer. urol. Ass. 100, 100 (1947).
Nesbit, R. M., and W. C. Baum: Endocrine control of prostatic carcinoma. J. Amer. med. Ass. 143, 1317 (1950).
O’Conor, V. J., jr., S. P. Chiang, and J. T. Grayhack: Is subcapsular orchiectomy a definitive procedure: Studies of hormone excretion before and after orchiectomy. J. Urol. (Baltimore) 89, 236 (1963).
O’Conor, R. ,E. Desantels, J. W. Pryor, P. L. Munson, and J. H. Harrison: Studies of hormonal changes in relation to cancer of the prostate: a progress report. J. Urol. (Baltimore) 81, 468 (1953).
Pearson, O. H., S. R. Bronson, C. C. Harrold, C. D. West, M. C. Li, G. P. MacLean, and M. B. Lipsett: Hypophysectomy in treatment of advanced cancer. J. Amer. med. Ass. 161, 17 (1956).
Rothauge, C. F., O. Weller, and E. Schuchardt: Die Wirkung von Diäthyldioxystilben-diphosphat (Honvan®) auf die Keimdrüse und die Gonadotropinausscheidung beim Manne. Klin. Wschr. 41, 90 (1963).
Schirmer, H. K. A., G. P. Murphy, and W. W. Scott: Hormonal therapy of prostatic cancer. A correlation between histologic differentiation of prostatic cancer and the clinical course of the disease. Urol. Digest, 15, September 1965.
Scott, W. W.: Regulators of prostatic growth. Trans. Amer. Ass. gen.-urin. Surg. 47, 168 (1956).
Scott, W. W., and H. K. A. Schirmer: Hypophysectomy for disseminated prostatic cancer. In Essays in experimental biology. Chicago: University of Chicago Press 1962, page 175.
Smith, E. J.R., K.J. Gurling, and D.N. Baron: The effect of hypophysectomy in advanced carcinoma of the prostate., Brit. J. Urol. 31, 181 (1959).
Whitmore, W. F.,jr..: The rationale and results of ablative surgery for prostatic cancer. Cancer (Philad.) 16, 1119 (1963).
Wildermuth, O., D. Parker, J. O. Archambeau, and C. Chahbazian: Management of diffuse metastasis from carcinoma of the prostate. J. Amer. med. Ass. 172, 1607 (1960).
Young, S.: Pituitary necrosis due to implants of radioactive gold and yttrium. Lancet 1, 548 (1957).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1967 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Hodges, C.V., Kirchheim, D. (1967). Hormone Treatment of Cancer of the Prostate. In: Manuila, L., Moles, S., Rentchnick, P. (eds) New Trends in the Treatment of Cancer. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 8. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-87620-2_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-87620-2_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-87622-6
Online ISBN: 978-3-642-87620-2
eBook Packages: Springer Book Archive